跳至主要内容
临床试验/JPRN-UMIN000042481
JPRN-UMIN000042481招募中未知

Investigating glycemic controls achieved in one year after discharge among type2 diabetic inpatients who received semaglutide via protecting beta-cell function. - Investigating glycemic controls achieved in one year after discharge among type2 diabetic inpatients who received semaglutide via protecting beta-cell function.

Saiseikai Yokohamashi Nanbu Hospital0 个研究点目标入组 80 人开始时间: 2020年11月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with severe liver dysfunction 2) Patients with severe renal dysfunction(eGFR<30ml/min/1.73) 3) Patients with fasting serum CPR <0.5 or postprandial serum CPR <1.0 4) Patinet with diabetic ketoacidosis 5) Patient with infection 6) Patients taking steroid 7) Patients with malignant tumor currently undergoing treatment 8) Pregnant or lactating woman 9) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor

研究者

相似试验